Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Omid Cameron Farokhzad, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
completed student projects
Development of Targeted Nanoparticle to Facilitate Drug Delivery for Treating Atherosclerois
Summer, 06/25/07 - 08/17/07

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01HL127464 (TABAS, IRA A) Jan 1, 2016 - Dec 31, 2020
    NIH
    Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics
    Role: Principal Investigator
  2. R01EB015419 (FAROKHZAD, OMID C) Apr 15, 2012 - Mar 31, 2017
    NIH
    Development of FcRn-Targeted Nanoparticles for Efficient Oral Delivery of Insulin
    Role: Principal Investigator
  3. K08EB003647 (FAROKHZAD, OMID C) Mar 1, 2005 - Mar 30, 2011
    NIH
    Development of Disease-Specific Drug Delivery Vehicles
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ferdosi S, Stukalov A, Hasan M, Tangeysh B, Brown TR, Wang T, Elgierari EM, Zhao X, Huang Y, Alavi A, Lee-McMullen B, Chu J, Figa M, Tao W, Wang J, Goldberg M, O'Brien ES, Xia H, Stolarczyk C, Weissleder R, Farias V, Batzoglou S, Siddiqui A, Farokhzad OC, Hornburg D. Enhanced Competition at the Nano-Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes. Adv Mater. 2022 Nov; 34(44):e2206008. PMID: 35986672.
    Citations:    Fields:    
  2. Tao W, Farokhzad OC. Theranostic Nanomedicine in the NIR-II Window: Classification, Fabrication, and Biomedical Applications. Chem Rev. 2022 03 23; 122(6):5405-5407. PMID: 35317560.
    Citations:    Fields:    
  3. Ferdosi S, Tangeysh B, Brown TR, Everley PA, Figa M, McLean M, Elgierari EM, Zhao X, Garcia VJ, Wang T, Chang MEK, Riedesel K, Chu J, Mahoney M, Xia H, O'Brien ES, Stolarczyk C, Harris D, Platt TL, Ma P, Goldberg M, Langer R, Flory MR, Benz R, Tao W, Cuevas JC, Batzoglou S, Blume JE, Siddiqui A, Hornburg D, Farokhzad OC. Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano-bio interactions. Proc Natl Acad Sci U S A. 2022 03 15; 119(11):e2106053119. PMID: 35275789; PMCID: PMC8931255.
    Citations:    Fields:    
  4. Kamaly N, Farokhzad OC, Corbo C. Nanoparticle protein corona evolution: from biological impact to biomarker discovery. Nanoscale. 2022 Feb 03; 14(5):1606-1620. PMID: 35076049.
    Citations: 2     Fields:    
  5. Molinaro R, Yu M, Sausen G, Bichsel CA, Corbo C, Folco EJ, Lee GY, Liu Y, Tesmenitsky Y, Shvartz E, Sukhova GK, Kloss F, Croce KJ, Farokhzad OC, Shi J, Libby P. Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity. Cardiovasc Res. 2021 11 22; 117(13):2652-2663. PMID: 33751034; PMCID: PMC8783386.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  6. Liu Y, Zou Y, Feng C, Lee A, Yin J, Chung R, Park JB, Rizos H, Tao W, Zheng M, Farokhzad OC, Shi B. Correction to Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy. Nano Lett. 2021 Nov 24; 21(22):9834. PMID: 34726061.
    Citations:    Fields:    
  7. Lin YX, Wang Y, Ding J, Jiang A, Wang J, Yu M, Blake S, Liu S, Bieberich CJ, Farokhzad OC, Mei L, Wang H, Shi J. Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models. Sci Transl Med. 2021 06 23; 13(599). PMID: 34162754; PMCID: PMC8284983.
    Citations: 11     Fields:    Translation:HumansCells
  8. Chen W, Liu C, Ji X, Joseph J, Tang Z, Ouyang J, Xiao Y, Kong N, Joshi N, Farokhzad OC, Tao W, Xie T. Stanene-Based Nanosheets for ß-Elemene Delivery and Ultrasound-Mediated Combination Cancer Therapy. Angew Chem Int Ed Engl. 2021 03 22; 60(13):7155-7164. PMID: 33434327.
    Citations: 13     Fields:    Translation:HumansCells
  9. Liu Y, Wang J, Xiong Q, Hornburg D, Tao W, Farokhzad OC. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection. Acc Chem Res. 2021 01 19; 54(2):291-301. PMID: 33180454.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  10. Corbo C, Li AA, Poustchi H, Lee GY, Stacks S, Molinaro R, Ma P, Platt T, Behzadi S, Langer R, Farias V, Farokhzad OC. Analysis of the Human Plasma Proteome Using Multi-Nanoparticle Protein Corona for Detection of Alzheimer's Disease. Adv Healthc Mater. 2021 01; 10(2):e2000948. PMID: 33169521.
    Citations: 1     Fields:    Translation:Humans
  11. Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020; 5(11):847-860. PMID: 33078077; PMCID: PMC7556605.
    Citations: 43     
  12. Islam MA, Rice J, Reesor E, Zope H, Tao W, Lim M, Ding J, Chen Y, Aduluso D, Zetter BR, Farokhzad OC, Shi J. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice. Biomaterials. 2021 01; 266:120431. PMID: 33099060.
    Citations: 20     Fields:    Translation:AnimalsCells
  13. Xiao Y, Tang Z, Wang J, Liu C, Kong N, Farokhzad OC, Tao W. Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers. Angew Chem Int Ed Engl. 2020 11 02; 59(45):19787-19795. PMID: 32705745.
    Citations: 9     Fields:    Translation:Humans
  14. Tao W, Yurdagul A, Kong N, Li W, Wang X, Doran AC, Feng C, Wang J, Islam MA, Farokhzad OC, Tabas I, Shi J. siRNA nanoparticles targeting CaMKII? in lesional macrophages improve atherosclerotic plaque stability in mice. Sci Transl Med. 2020 07 22; 12(553). PMID: 32718990.
    Citations: 37     Fields:    Translation:AnimalsCells
  15. Blume JE, Manning WC, Troiano G, Hornburg D, Figa M, Hesterberg L, Platt TL, Zhao X, Cuaresma RA, Everley PA, Ko M, Liou H, Mahoney M, Ferdosi S, Elgierari EM, Stolarczyk C, Tangeysh B, Xia H, Benz R, Siddiqui A, Carr SA, Ma P, Langer R, Farias V, Farokhzad OC. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nat Commun. 2020 07 22; 11(1):3662. PMID: 32699280; PMCID: PMC7376165.
    Citations: 23     Fields:    Translation:Humans
  16. Hu K, Xie L, Zhang Y, Hanyu M, Yang Z, Nagatsu K, Suzuki H, Ouyang J, Ji X, Wei J, Xu H, Farokhzad OC, Liang SH, Wang L, Tao W, Zhang MR. Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy. Nat Commun. 2020 06 08; 11(1):2778. PMID: 32513979.
    Citations: 36     Fields:    Translation:HumansAnimalsCells
  17. Li Y, Ding J, Xu X, Shi R, Saw PE, Wang J, Chung S, Li W, Aljaeid BM, Lee RJ, Tao W, Teng L, Farokhzad OC, Shi J. Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy. Nano Lett. 2020 07 08; 20(7):4857-4863. PMID: 32479088.
    Citations: 7     Fields:    Translation:HumansCells
  18. Kong N, Ji X, Wang J, Sun X, Chen G, Fan T, Liang W, Zhang H, Xie A, Farokhzad OC, Tao W. ROS-Mediated Selective Killing Effect of Black Phosphorus: Mechanistic Understanding and Its Guidance for Safe Biomedical Applications. Nano Lett. 2020 05 13; 20(5):3943-3955. PMID: 32243175.
    Citations: 28     Fields:    Translation:HumansCells
  19. Saw PE, Xu X, Zhang M, Cao S, Farokhzad OC, Wu J. Nanostructure Engineering by Simple Tuning of Lipid Combinations. Angew Chem Int Ed Engl. 2020 04 06; 59(15):6249-6252. PMID: 32017368.
    Citations: 2     Fields:    Translation:AnimalsCells
  20. Son S, Nam J, Zenkov I, Ochyl LJ, Xu Y, Scheetz L, Shi J, Farokhzad OC, Moon JJ. Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination. Nano Lett. 2020 03 11; 20(3):1499-1509. PMID: 32023415.
    Citations: 15     Fields:    Translation:AnimalsCellsPHPublic Health
  21. Liu Y, Zou Y, Feng C, Lee A, Yin J, Chung R, Park JB, Rizos H, Tao W, Zheng M, Farokhzad OC, Shi B. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy. Nano Lett. 2020 03 11; 20(3):1637-1646. PMID: 32013452.
    Citations: 22     Fields:    Translation:AnimalsCells
  22. Li S, Saw PE, Lin C, Nie Y, Tao W, Farokhzad OC, Zhang L, Xu X. Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy. Biomaterials. 2020 03; 234:119760. PMID: 31945619.
    Citations: 19     Fields:    Translation:HumansCells
  23. Kong N, Tao W, Ling X, Wang J, Xiao Y, Shi S, Ji X, Shajii A, Gan ST, Kim NY, Duda DG, Xie T, Farokhzad OC, Shi J. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition. Sci Transl Med. 2019 12 18; 11(523). PMID: 31852795; PMCID: PMC7024563.
    Citations: 46     Fields:    Translation:HumansAnimalsCells
  24. Ji X, Kang Y, Ouyang J, Chen Y, Artzi D, Zeng X, Xiao Y, Feng C, Qi B, Kim NY, Saw PE, Kong N, Farokhzad OC, Tao W. Synthesis of Ultrathin Biotite Nanosheets as an Intelligent Theranostic Platform for Combination Cancer Therapy. Adv Sci (Weinh). 2019 Oct 02; 6(19):1901211. PMID: 31592423; PMCID: PMC6774039.
    Citations: 25     Fields:    
  25. Ouyang J, Feng C, Ji X, Li L, Gutti HK, Kim NY, Artzi D, Xie A, Kong N, Liu YN, Tearney GJ, Sui X, Tao W, Farokhzad OC. 2D Monoelemental Germanene Quantum Dots: Synthesis as Robust Photothermal Agents for Photonic Cancer Nanomedicine. Angew Chem Int Ed Engl. 2019 09 16; 58(38):13405-13410. PMID: 31365775.
    Citations: 17     Fields:    Translation:Humans
  26. Saw PE, Yao H, Lin C, Tao W, Farokhzad OC, Xu X. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy. Nano Lett. 2019 09 11; 19(9):5967-5974. PMID: 31381852.
    Citations: 15     Fields:    Translation:HumansCells
  27. Tao W, Kong N, Ji X, Zhang Y, Sharma A, Ouyang J, Qi B, Wang J, Xie N, Kang C, Zhang H, Farokhzad OC, Kim JS. Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications. Chem Soc Rev. 2019 Jun 04; 48(11):2891-2912. PMID: 31120049.
    Citations: 47     Fields:    Translation:HumansAnimals
  28. Tao W, Wang J, Parak WJ, Farokhzad OC, Shi J. Nanobuffering of pH-Responsive Polymers: A Known but Sometimes Overlooked Phenomenon and Its Biological Applications. ACS Nano. 2019 05 28; 13(5):4876-4882. PMID: 30985108; PMCID: PMC6748625.
    Citations: 10     Fields:    
  29. Shi S, Kong N, Feng C, Shajii A, Bejgrowicz C, Tao W, Farokhzad OC. Drug Delivery Strategies for the Treatment of Metabolic Diseases. Adv Healthc Mater. 2019 06; 8(12):e1801655. PMID: 30957991.
    Citations: 10     Fields:    Translation:HumansAnimals
  30. Ling X, Tu J, Wang J, Shajii A, Kong N, Feng C, Zhang Y, Yu M, Xie T, Bharwani Z, Aljaeid BM, Shi B, Tao W, Farokhzad OC. Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy. ACS Nano. 2019 01 22; 13(1):357-370. PMID: 30485068; PMCID: PMC7049173.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  31. Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, Kantoff PW, Farokhzad OC, Zetter BR, Shi J. Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nat Biomed Eng. 2018 Dec; 2(12):968. PMID: 31015729.
    Citations: 3     Fields:    
  32. Yu M, Ortega CA, Si K, Molinaro R, Schoen FJ, Leitao RFC, Xu X, Mahmoudi M, Ahn S, Liu J, Saw PE, Lee IH, Brayner MMB, Lotfi A, Shi J, Libby P, Jon S, Farokhzad OC. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Theranostics. 2018; 8(21):6008-6024. PMID: 30613278; PMCID: PMC6299428.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  33. Lim JM, Cai T, Mandaric S, Chopra S, Han H, Jang S, Il Choi W, Langer R, Farokhzad OC, Karnik R. Drug loading augmentation in polymeric nanoparticles using a coaxial turbulent jet mixer: Yong investigator perspective. J Colloid Interface Sci. 2019 Mar 07; 538:45-50. PMID: 30500466.
    Citations:    Fields:    
  34. Xu X, Wu J, Liu S, Saw PE, Tao W, Li Y, Krygsman L, Yegnasubramanian S, De Marzo AM, Shi J, Bieberich CJ, Farokhzad OC. Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. Small. 2018 10; 14(41):e1802565. PMID: 30230235.
    Citations: 14     Fields:    Translation:HumansCells
  35. Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, Kantoff PW, Farokhzad OC, Zetter BR, Shi J. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nat Biomed Eng. 2018 11; 2(11):850-864. PMID: 31015614; PMCID: PMC6486184.
    Citations: 64     Fields:    Translation:HumansAnimalsCells
  36. Tao W, Ji X, Zhu X, Li L, Wang J, Zhang Y, Saw PE, Li W, Kong N, Islam MA, Gan T, Zeng X, Zhang H, Mahmoudi M, Tearney GJ, Farokhzad OC. Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics. Adv Mater. 2018 Sep; 30(38):e1802061. PMID: 30043416; PMCID: PMC7028391.
    Citations: 48     Fields:    Translation:Humans
  37. Ling X, Chen X, Riddell IA, Tao W, Wang J, Hollett G, Lippard SJ, Farokhzad OC, Shi J, Wu J. Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance. Nano Lett. 2018 07 11; 18(7):4618-4625. PMID: 29902013; PMCID: PMC6271432.
    Citations: 25     Fields:    Translation:HumansAnimalsCells
  38. Parak WJ, Chan WWC, Chhowalla M, Farokhzad O, Glotzer S, Gogotsi Y, Hammond PT, Hersam MC, Javey A, Kagan CR, Kataoka K, Khademhosseini A, Kotov NA, Lee ST, Lee YH, Li Y, Millstone J, Mulvaney PA, Nel AE, Nordlander PJ, Penner RM, Rogach AL, Schaak RE, Stevens MM, Wee ATS, Willson CG, Weiss PS. Helmuth Möhwald (1946-2018). ACS Nano. 2018 Apr 24; 12(4):3053-3055. PMID: 29676563.
    Citations:    Fields:    
  39. Zhu X, Ji X, Kong N, Chen Y, Mahmoudi M, Xu X, Ding L, Tao W, Cai T, Li Y, Gan T, Barrett A, Bharwani Z, Chen H, Farokhzad OC. Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy. ACS Nano. 2018 03 27; 12(3):2922-2938. PMID: 29406760.
    Citations: 29     Fields:    Translation:HumansAnimalsCells
  40. Zheng M, Tao W, Zou Y, Farokhzad OC, Shi B. Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy. Trends Biotechnol. 2018 05; 36(5):562-575. PMID: 29422412.
    Citations: 36     Fields:    Translation:HumansAnimals
  41. Chan WWC, Chhowalla M, Farokhzad O, Glotzer S, Gogotsi Y, Hafner JH, Hammond PT, Hersam MC, Javey A, Kagan CR, Kataoka K, Khademhosseini A, Kotov NA, Lee ST, Li Y, Millstone J, Möhwald H, Mulvaney PC, Nel AE, Nordlander PJ, Parak WJ, Penner RM, Rogach AL, Schaak RE, Stevens MM, Wee ATS, Willson CG, Fernandez LE, Weiss PS. A Big Year Ahead for Nano in 2018. ACS Nano. 2017 12 26; 11(12):11755-11757. PMID: 29294604.
    Citations:    Fields:    
  42. Bertrand N, Grenier P, Mahmoudi M, Lima EM, Appel EA, Dormont F, Lim JM, Karnik R, Langer R, Farokhzad OC. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Nat Commun. 2017 10 03; 8(1):777. PMID: 28974673.
    Citations: 121     Fields:    Translation:AnimalsCells
  43. Mahmoudi M, Yu M, Serpooshan V, Wu JC, Langer R, Lee RT, Karp JM, Farokhzad OC. Multiscale technologies for treatment of ischemic cardiomyopathy. Nat Nanotechnol. 2017 09 06; 12(9):845-855. PMID: 28875984.
    Citations: 33     Fields:    Translation:HumansAnimals
  44. Wang J, Tao W, Chen X, Farokhzad OC, Liu G. Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems. Theranostics. 2017; 7(16):3915-3919. PMID: 29109787.
    Citations: 12     Fields:    Translation:Humans
  45. Behzadi S, Luther GA, Harris MB, Farokhzad OC, Mahmoudi M. Nanomedicine for safe healing of bone trauma: Opportunities and challenges. Biomaterials. 2017 Nov; 146:168-182. PMID: 28918266; PMCID: PMC5706116.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  46. Kakkar A, Traverso G, Farokhzad OC, Weissleder R, Langer R. Evolution of macromolecular complexity in drug delivery systems. Nat Rev Chem. 2017 Aug; 1(8). PMID: 31286060; PMCID: PMC6613785.
    Citations: 41     
  47. Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, Jon S, Fisher EA, Farokhzad OC. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice. Adv Healthc Mater. 2017 Oct; 6(20). PMID: 28730752.
    Citations: 25     Fields:    Translation:AnimalsCells
  48. Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, Brown D, Alkilany AM, Farokhzad OC, Mahmoudi M. Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev. 2017 Jul 17; 46(14):4218-4244. PMID: 28585944; PMCID: PMC5593313.
    Citations: 347     Fields:    Translation:HumansCells
  49. Tao W, Ji X, Xu X, Islam MA, Li Z, Chen S, Saw PE, Zhang H, Bharwani Z, Guo Z, Shi J, Farokhzad OC. Antimonene Quantum Dots: Synthesis and Application as Near-Infrared Photothermal Agents for Effective Cancer Therapy. Angew Chem Int Ed Engl. 2017 09 18; 56(39):11896-11900. PMID: 28640986; PMCID: PMC5608550.
    Citations: 68     Fields:    Translation:HumansAnimalsCells
  50. Shi B, Zheng M, Tao W, Chung R, Jin D, Ghaffari D, Farokhzad OC. Challenges in DNA Delivery and Recent Advances in Multifunctional Polymeric DNA Delivery Systems. Biomacromolecules. 2017 Aug 14; 18(8):2231-2246. PMID: 28661127.
    Citations: 39     Fields:    Translation:HumansAnimals
  51. Xu X, Saw PE, Tao W, Li Y, Ji X, Bhasin S, Liu Y, Ayyash D, Rasmussen J, Huo M, Shi J, Farokhzad OC. ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy. Adv Mater. 2017 Sep; 29(33). PMID: 28681981; PMCID: PMC5681219.
    Citations: 51     Fields:    Translation:Humans
  52. Xu X, Saw PE, Tao W, Li Y, Ji X, Yu M, Mahmoudi M, Rasmussen J, Ayyash D, Zhou Y, Farokhzad OC, Shi J. Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy. Nano Lett. 2017 07 12; 17(7):4427-4435. PMID: 28636389; PMCID: PMC5615408.
    Citations: 36     Fields:    Translation:HumansAnimalsCells
  53. Zhu X, Tao W, Liu D, Wu J, Guo Z, Ji X, Bharwani Z, Zhao L, Zhao X, Farokhzad OC, Shi J. Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo. Theranostics. 2017; 7(7):1990-2002. PMID: 28638484.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  54. Chopra S, Bertrand N, Lim JM, Wang A, Farokhzad OC, Karnik R. Design of Insulin-Loaded Nanoparticles Enabled by Multistep Control of Nanoprecipitation and Zinc Chelation. ACS Appl Mater Interfaces. 2017 Apr 05; 9(13):11440-11450. PMID: 28323414; PMCID: PMC5557377.
    Citations: 7     Fields:    
  55. Xu X, Wu J, Liu Y, Saw PE, Tao W, Yu M, Zope H, Si M, Victorious A, Rasmussen J, Ayyash D, Farokhzad OC, Shi J. Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy. ACS Nano. 2017 03 28; 11(3):2618-2627. PMID: 28240870; PMCID: PMC5626580.
    Citations: 46     Fields:    Translation:HumansAnimalsCells
  56. Corbo C, Molinaro R, Tabatabaei M, Farokhzad OC, Mahmoudi M. Personalized protein corona on nanoparticles and its clinical implications. Biomater Sci. 2017 Feb 28; 5(3):378-387. PMID: 28133653; PMCID: PMC5592724.
    Citations: 54     Fields:    Translation:HumansAnimalsCells
  57. Khademhosseini A, Chan WW, Chhowalla M, Glotzer SC, Gogotsi Y, Hafner JH, Hammond PT, Hersam MC, Javey A, Kagan CR, Kotov NA, Lee ST, Li Y, Möhwald H, Mulvaney PA, Nel AE, Parak WJ, Penner RM, Rogach AL, Schaak RE, Stevens MM, Wee AT, Brinker J, Chen X, Chi L, Crommie M, Dekker C, Farokhzad O, Gerber C, Ginger DS, Irvine DJ, Kiessling LL, Kostarelos K, Landes C, Lee T, Leggett GJ, Liang XJ, Liz-Marzán L, Millstone J, Odom TW, Ozcan A, Prato M, Rao CN, Sailor MJ, Weiss E, Weiss PS. Nanoscience and Nanotechnology Cross Borders. ACS Nano. 2017 02 28; 11(2):1123-1126. PMID: 28199099.
    Citations:    Fields:    
  58. Saw PE, Yu M, Choi M, Lee E, Jon S, Farokhzad OC. Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy. Biomaterials. 2017 04; 123:118-126. PMID: 28167390.
    Citations: 7     Fields:    Translation:AnimalsCells
  59. Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017 01; 17(1):20-37. PMID: 27834398; PMCID: PMC5575742.
    Citations: 945     Fields:    Translation:Humans
  60. Kamaly N, He JC, Ausiello DA, Farokhzad OC. Nanomedicines for renal disease: current status and future applications. Nat Rev Nephrol. 2016 Dec; 12(12):738-753. PMID: 27795549.
    Citations: 44     Fields:    Translation:Humans
  61. Saw PE, Park J, Jon S, Farokhzad OC. A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectin. Nanomedicine. 2017 02; 13(2):713-722. PMID: 27769887.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  62. Caracciolo G, Farokhzad OC, Mahmoudi M. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. Trends Biotechnol. 2017 03; 35(3):257-264. PMID: 27663778.
    Citations: 73     Fields:    Translation:HumansAnimals
  63. Cisterna BA, Kamaly N, Choi WI, Tavakkoli A, Farokhzad OC, Vilos C. Targeted nanoparticles for colorectal cancer. Nanomedicine (Lond). 2016 Sep; 11(18):2443-56. PMID: 27529192.
    Citations: 35     Fields:    Translation:Humans
  64. Liu Y, Gunda V, Zhu X, Xu X, Wu J, Askhatova D, Farokhzad OC, Parangi S, Shi J. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer. Proc Natl Acad Sci U S A. 2016 07 12; 113(28):7750-5. PMID: 27342857; PMCID: PMC4948349.
    Citations: 25     Fields:    Translation:HumansAnimalsCells
  65. Xu X, Wu J, Liu Y, Yu M, Zhao L, Zhu X, Bhasin S, Li Q, Ha E, Shi J, Farokhzad OC. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy. Angew Chem Int Ed Engl. 2016 06 13; 55(25):7091-7094. PMID: 27140428; PMCID: PMC4972612.
    Citations: 47     Fields:    Translation:HumansCells
  66. Xue Y, Xu X, Zhang XQ, Farokhzad OC, Langer R. Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proc Natl Acad Sci U S A. 2016 May 17; 113(20):5552-7. PMID: 27140638; PMCID: PMC4878518.
    Citations: 47     Fields:    Translation:AnimalsCells
  67. Kamaly N, Fredman G, Fojas JJ, Subramanian M, Choi WI, Zepeda K, Vilos C, Yu M, Gadde S, Wu J, Milton J, Carvalho Leitao R, Rosa Fernandes L, Hasan M, Gao H, Nguyen V, Harris J, Tabas I, Farokhzad OC. Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis. ACS Nano. 2016 05 24; 10(5):5280-92. PMID: 27100066.
    Citations: 53     Fields:    Translation:Animals
  68. Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. Chem Rev. 2016 Feb 24; 116(4):2602-63. PMID: 26854975; PMCID: PMC5509216.
    Citations: 359     Fields:    Translation:Cells
  69. Zhu X, Wu J, Shan W, Tao W, Zhao L, Lim JM, D'Ortenzio M, Karnik R, Huang Y, Shi J, Farokhzad OC. Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins. Angew Chem Int Ed Engl. 2016 Mar 01; 55(10):3309-12. PMID: 26846161; PMCID: PMC4835185.
    Citations: 16     Fields:    Translation:HumansCells
  70. Chung BL, Toth MJ, Kamaly N, Sei YJ, Becraft J, Mulder WJ, Fayad ZA, Farokhzad OC, Kim Y, Langer R. Nanomedicines for Endothelial Disorders. Nano Today. 2015 Dec 01; 10(6):759-776. PMID: 26955397; PMCID: PMC4778260.
    Citations: 6     
  71. Miller MA, Gadde S, Pfirschke C, Engblom C, Sprachman MM, Kohler RH, Yang KS, Laughney AM, Wojtkiewicz G, Kamaly N, Bhonagiri S, Pittet MJ, Farokhzad OC, Weissleder R. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Sci Transl Med. 2015 Nov 18; 7(314):314ra183. PMID: 26582898.
    Citations: 113     Fields:    Translation:HumansAnimalsCells
  72. Miller MA, Zheng YR, Gadde S, Pfirschke C, Zope H, Engblom C, Kohler RH, Iwamoto Y, Yang KS, Askevold B, Kolishetti N, Pittet M, Lippard SJ, Farokhzad OC, Weissleder R. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun. 2015 Oct 27; 6:8692. PMID: 26503691; PMCID: PMC4711745.
    Citations: 135     Fields:    Translation:HumansAnimalsCells
  73. Yu M, Wu J, Shi J, Farokhzad OC. Nanotechnology for protein delivery: Overview and perspectives. J Control Release. 2016 10 28; 240:24-37. PMID: 26458789.
    Citations: 55     Fields:    Translation:HumansAnimals
  74. Farokhzad OC. Nanotechnology: Platelet mimicry. Nature. 2015 Oct 01; 526(7571):47-8. PMID: 26375011.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  75. Yameen B, Vilos C, Choi WI, Whyte A, Huang J, Pollit L, Farokhzad OC. Drug Delivery Nanocarriers from a Fully Degradable PEG-Conjugated Polyester with a Reduction-Responsive Backbone. Chemistry. 2015 Aug 03; 21(32):11325-9. PMID: 26177931.
    Citations: 5     Fields:    Translation:Humans
  76. Wu J, Zhao L, Xu X, Bertrand N, Choi WI, Yameen B, Shi J, Shah V, Mulvale M, MacLean JL, Farokhzad OC. Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics. Angew Chem Int Ed Engl. 2015 Aug 03; 54(32):9218-23. PMID: 26119453.
    Citations: 16     Fields:    Translation:HumansCells
  77. Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, Perro M, Vrbanac VD, Tager AM, Shi J, Yethon JA, Farokhzad OC, Langer R, Starnbach MN, von Andrian UH. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science. 2015 Jun 19; 348(6241):aaa8205. PMID: 26089520.
    Citations: 166     Fields:    Translation:AnimalsCellsPHPublic Health
  78. Zhu X, Xu Y, Solis LM, Tao W, Wang L, Behrens C, Xu X, Zhao L, Liu D, Wu J, Zhang N, Wistuba II, Farokhzad OC, Zetter BR, Shi J. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proc Natl Acad Sci U S A. 2015 Jun 23; 112(25):7779-84. PMID: 26056316; PMCID: PMC4485147.
    Citations: 50     Fields:    Translation:Humans
  79. Saw PE, Park J, Lee E, Ahn S, Lee J, Kim H, Kim J, Choi M, Farokhzad OC, Jon S. Effect of PEG pairing on the efficiency of cancer-targeting liposomes. Theranostics. 2015; 5(7):746-54. PMID: 25897339.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  80. Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv. 2015; 12(9):1459-73. PMID: 25813361.
    Citations: 42     Fields:    Translation:HumansAnimals
  81. Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokzhad O, Tabas I. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med. 2015 Feb 18; 7(275):275ra20. PMID: 25695999.
    Citations: 130     Fields:    Translation:Animals
  82. Leoni G, Neumann PA, Kamaly N, Quiros M, Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, Argyris I, Rijcken E, Kusters D, Reutelingsperger C, Perretti M, Parkos CA, Farokhzad OC, Neish AS, Nusrat A. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest. 2015 Mar 02; 125(3):1215-27. PMID: 25664854; PMCID: PMC4362251.
    Citations: 124     Fields:    Translation:HumansAnimalsCells
  83. Xu X, Ho W, Zhang X, Bertrand N, Farokhzad O. Cancer nanomedicine: from targeted delivery to combination therapy. Trends Mol Med. 2015 Apr; 21(4):223-32. PMID: 25656384.
    Citations: 140     Fields:    Translation:HumansAnimalsCells
  84. Maldonado RA, LaMothe RA, Ferrari JD, Zhang AH, Rossi RJ, Kolte PN, Griset AP, O'Neil C, Altreuter DH, Browning E, Johnston L, Farokhzad OC, Langer R, Scott DW, von Andrian UH, Kishimoto TK. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc Natl Acad Sci U S A. 2015 Jan 13; 112(2):E156-65. PMID: 25548186; PMCID: PMC4299193.
    Citations: 170     Fields:    Translation:HumansAnimalsCells
  85. Choi WI, Kamaly N, Riol-Blanco L, Lee IH, Wu J, Swami A, Vilos C, Yameen B, Yu M, Shi J, Tabas I, von Andrian UH, Jon S, Farokhzad OC. A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins. Nano Lett. 2014 Nov 12; 14(11):6449-55. PMID: 25333768.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  86. Zhang XQ, Even-Or O, Xu X, van Rosmalen M, Lim L, Gadde S, Farokhzad OC, Fisher EA. Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis. Adv Healthc Mater. 2015 Jan 28; 4(2):228-36. PMID: 25156796.
    Citations: 34     Fields:    Translation:AnimalsCells
  87. Wu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, John R, Ray S, Xu X, Zhang X, Kantoff PW, Farokhzad OC. Development of multinuclear polymeric nanoparticles as robust protein nanocarriers. Angew Chem Int Ed Engl. 2014 Aug 18; 53(34):8975-9. PMID: 24990548.
    Citations: 29     Fields:    
  88. Swami A, Reagan MR, Basto P, Mishima Y, Kamaly N, Glavey S, Zhang S, Moschetta M, Seevaratnam D, Zhang Y, Liu J, Memarzadeh M, Wu J, Manier S, Shi J, Bertrand N, Lu ZN, Nagano K, Baron R, Sacco A, Roccaro AM, Farokhzad OC, Ghobrial IM. Engineered nanomedicine for myeloma and bone microenvironment targeting. Proc Natl Acad Sci U S A. 2014 Jul 15; 111(28):10287-92. PMID: 24982170.
    Citations: 86     Fields:    Translation:HumansAnimalsCells
  89. Yameen B, Choi WI, Vilos C, Swami A, Shi J, Farokhzad OC. Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release. 2014 Sep 28; 190:485-99. PMID: 24984011.
    Citations: 163     Fields:    Translation:HumansCells
  90. Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle technologies for oral drug delivery. Clin Gastroenterol Hepatol. 2014 Oct; 12(10):1605-10. PMID: 24981782.
    Citations: 27     Fields:    Translation:Humans
  91. Lim JM, Swami A, Gilson LM, Chopra S, Choi S, Wu J, Langer R, Karnik R, Farokhzad OC. Ultra-high throughput synthesis of nanoparticles with homogeneous size distribution using a coaxial turbulent jet mixer. ACS Nano. 2014 Jun 24; 8(6):6056-65. PMID: 24824296.
    Citations: 38     Fields:    Translation:HumansCells
  92. Gadde S, Even-Or O, Kamaly N, Hasija A, Gagnon PG, Adusumilli KH, Erakovic A, Pal AK, Zhang XQ, Kolishetti N, Shi J, Fisher EA, Farokhzad OC. Development of therapeutic polymeric nanoparticles for the resolution of inflammation. Adv Healthc Mater. 2014 Sep; 3(9):1448-1456. PMID: 24659608.
    Citations: 13     Fields:    Translation:Animals
  93. Shi J, Xu Y, Xu X, Zhu X, Pridgen E, Wu J, Votruba AR, Swami A, Zetter BR, Farokhzad OC. Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. Nanomedicine. 2014 Jul; 10(5):897-900. PMID: 24650883; PMCID: PMC4077924.
    Citations: 15     Fields:    Translation:HumansCells
  94. Ilyinskii PO, Roy CJ, O'Neil CP, Browning EA, Pittet LA, Altreuter DH, Alexis F, Tonti E, Shi J, Basto PA, Iannacone M, Radovic-Moreno AF, Langer RS, Farokhzad OC, von Andrian UH, Johnston LP, Kishimoto TK. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine. 2014 May 19; 32(24):2882-95. PMID: 24593999.
    Citations: 61     Fields:    Translation:AnimalsCells
  95. Gendelman HE, Balogh LP, Bawa R, Bradbury M, Chang EH, Chiu W, Farokhzad O, Foldvari M, Lanza G, Wang K. The 4th Annual Meeting of the American Society for Nanomedicine. J Neuroimmune Pharmacol. 2014 Mar; 9 Suppl 1:S1-3. PMID: 24550132.
    Citations:    Fields:    Translation:Humans
  96. Wang AZ, Farokhzad OC. Current progress of aptamer-based molecular imaging. J Nucl Med. 2014 Mar; 55(3):353-6. PMID: 24525205.
    Citations: 28     Fields:    Translation:Humans
  97. Kim Y, Lobatto ME, Kawahara T, Lee Chung B, Mieszawska AJ, Sanchez-Gaytan BL, Fay F, Senders ML, Calcagno C, Becraft J, Tun Saung M, Gordon RE, Stroes ES, Ma M, Farokhzad OC, Fayad ZA, Mulder WJ, Langer R. Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. Proc Natl Acad Sci U S A. 2014 Jan 21; 111(3):1078-83. PMID: 24395808.
    Citations: 59     Fields:    Translation:HumansAnimalsCells
  98. Pridgen EM, Alexis F, Kuo TT, Levy-Nissenbaum E, Karnik R, Blumberg RS, Langer R, Farokhzad OC. Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Sci Transl Med. 2013 Nov 27; 5(213):213ra167. PMID: 24285486.
    Citations: 104     Fields:    Translation:Animals
  99. Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014 Feb; 66:2-25. PMID: 24270007.
    Citations: 589     Fields:    Translation:HumansAnimals
  100. Valencia PM, Pridgen EM, Rhee M, Langer R, Farokhzad OC, Karnik R. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. ACS Nano. 2013 Dec 23; 7(12):10671-80. PMID: 24215426.
    Citations: 49     Fields:    Translation:HumansAnimalsCells
  101. Xu X, Xie K, Zhang XQ, Pridgen EM, Park GY, Cui DS, Shi J, Wu J, Kantoff PW, Lippard SJ, Langer R, Walker GC, Farokhzad OC. Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug. Proc Natl Acad Sci U S A. 2013 Nov 12; 110(46):18638-43. PMID: 24167294.
    Citations: 93     Fields:    Translation:HumansCells
  102. Gianella A, Mieszawska AJ, Hoeben FJ, Janssen HM, Jarzyna PA, Cormode DP, Costa KD, Rao S, Farokhzad OC, Langer R, Fayad ZA, Mulder WJ. Synthesis and in vitro evaluation of a multifunctional and surface-switchable nanoemulsion platform. Chem Commun (Camb). 2013 Oct 21; 49(82):9392-4. PMID: 23877789.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  103. Kim Y, Fay F, Cormode DP, Sanchez-Gaytan BL, Tang J, Hennessy EJ, Ma M, Moore K, Farokhzad OC, Fisher EA, Mulder WJ, Langer R, Fayad ZA. Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics. ACS Nano. 2013 Nov 26; 7(11):9975-83. PMID: 24079940.
    Citations: 37     Fields:    Translation:AnimalsCells
  104. Kim Y, Lee Chung B, Ma M, Mulder WJ, Fayad ZA, Farokhzad OC, Langer R. Correction to Mass Production and Size Control of Lipid-Polymer Hybrid Nanoparticles through Controlled Microvortices. Nano Lett. 2013 Oct 9; 13(10):4997. PMID: 24041197.
    Citations:    
  105. Mieszawska AJ, Kim Y, Gianella A, van Rooy I, Priem B, Labarre MP, Ozcan C, Cormode DP, Petrov A, Langer R, Farokhzad OC, Fayad ZA, Mulder WJ. Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy. Bioconjug Chem. 2013 Sep 18; 24(9):1429-34. PMID: 23957728.
    Citations: 29     Fields:    Translation:HumansAnimalsCells
  106. Lim JM, Bertrand N, Valencia PM, Rhee M, Langer R, Jon S, Farokhzad OC, Karnik R. Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study. Nanomedicine. 2014 Feb; 10(2):401-9. PMID: 23969105; PMCID: PMC3951970.
    Citations: 26     Fields:    Translation:HumansAnimals
  107. Park J, Park S, Kim S, Lee IH, Saw PE, Lee K, Kim YC, Kim YJ, Farokhzad OC, Jeong YY, Jon S. HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy. J Mater Chem B. 2013 Sep 28; 1(36):4576-4583. PMID: 32261200.
    Citations: 1     Fields:    
  108. Johnstone TC, Kulak N, Pridgen EM, Farokhzad OC, Langer R, Lippard SJ. Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties. ACS Nano. 2013 Jul 23; 7(7):5675-83. PMID: 23697579.
    Citations: 24     Fields:    Translation:AnimalsCells
  109. Kamaly N, Fredman G, Subramanian M, Gadde S, Pesic A, Cheung L, Fayad ZA, Langer R, Tabas I, Farokhzad OC. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proc Natl Acad Sci U S A. 2013 Apr 16; 110(16):6506-11. PMID: 23533277.
    Citations: 83     Fields:    Translation:AnimalsCells
  110. Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013 Apr 15; 73(8):2412-7. PMID: 23423979.
    Citations: 437     Fields:    Translation:HumansAnimals
  111. Zhao W, Cui CH, Bose S, Guo D, Shen C, Wong WP, Halvorsen K, Farokhzad OC, Teo GS, Phillips JA, Dorfman DM, Karnik R, Karp JM. Bioinspired multivalent DNA network for capture and release of cells. Proc Natl Acad Sci U S A. 2012 Nov 27; 109(48):19626-31. PMID: 23150586.
    Citations: 54     Fields:    Translation:HumansCells
  112. Salvador-Morales C, Valencia PM, Gao W, Karnik R, Farokhzad OC. Spontaneous formation of heterogeneous patches on polymer-lipid core-shell particle surfaces during self-assembly. Small. 2013 Feb 25; 9(4):511-7. PMID: 23109494.
    Citations: 6     Fields:    
  113. Xiao Z, Ji C, Shi J, Pridgen EM, Frieder J, Wu J, Farokhzad OC. DNA self-assembly of targeted near-infrared-responsive gold nanoparticles for cancer thermo-chemotherapy. Angew Chem Int Ed Engl. 2012 Nov 19; 51(47):11853-7. PMID: 23081716.
    Citations: 65     Fields:    Translation:HumansAnimalsCells
  114. Valencia PM, Pridgen EM, Perea B, Gadde S, Sweeney C, Kantoff PW, Bander NH, Lippard SJ, Langer R, Karnik R, Farokhzad OC. Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles. Nanomedicine (Lond). 2013 May; 8(5):687-98. PMID: 23075285.
    Citations: 27     Fields:    Translation:HumansCells
  115. Valencia PM, Farokhzad OC, Karnik R, Langer R. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol. 2012 Oct; 7(10):623-9. PMID: 23042546; PMCID: PMC3654404.
    Citations: 124     Fields:    Translation:Humans
  116. Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Deliv Rev. 2012 Oct; 64(13):1363-84. PMID: 22917779.
    Citations: 71     Fields:    Translation:HumansAnimalsCells
  117. Farokhzad OC. Using ligands to target cancer cells. Clin Adv Hematol Oncol. 2012 Aug; 10(8):543-4. PMID: 23073055.
    Citations: 3     Fields:    Translation:HumansCells
  118. Kim Y, Lee Chung B, Ma M, Mulder WJ, Fayad ZA, Farokhzad OC, Langer R. Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. Nano Lett. 2012 Jul 11; 12(7):3587-91. PMID: 22716029.
    Citations: 50     Fields:    
  119. Graf N, Bielenberg DR, Kolishetti N, Muus C, Banyard J, Farokhzad OC, Lippard SJ. a(V)ß(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. ACS Nano. 2012 May 22; 6(5):4530-9. PMID: 22584163.
    Citations: 55     Fields:    Translation:HumansCells
  120. Xiao Z, Farokhzad OC. Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. ACS Nano. 2012 May 22; 6(5):3670-6. PMID: 22574989.
    Citations: 33     Fields:    Translation:Humans
  121. Mieszawska AJ, Gianella A, Cormode DP, Zhao Y, Meijerink A, Langer R, Farokhzad OC, Fayad ZA, Mulder WJ. Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging. Chem Commun (Camb). 2012 Jun 14; 48(47):5835-7. PMID: 22555311.
    Citations: 22     Fields:    
  122. Radovic-Moreno AF, Lu TK, Puscasu VA, Yoon CJ, Langer R, Farokhzad OC. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano. 2012 May 22; 6(5):4279-87. PMID: 22471841.
    Citations: 96     Fields:    Translation:Cells
  123. Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, Horhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, Tompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, Farokhzad OC, Langer R, Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med. 2012 Apr 04; 4(128):128ra39. PMID: 22491949.
    Citations: 341     Fields:    Translation:HumansAnimalsCells
  124. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012 Apr 07; 41(7):2971-3010. PMID: 22388185.
    Citations: 349     Fields:    Translation:Humans
  125. Xiao Z, Levy-Nissenbaum E, Alexis F, Lupták A, Teply BA, Chan JM, Shi J, Digga E, Cheng J, Langer R, Farokhzad OC. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano. 2012 Jan 24; 6(1):696-704. PMID: 22214176.
    Citations: 49     Fields:    Translation:HumansCells
  126. Chan JM, Rhee JW, Drum CL, Bronson RT, Golomb G, Langer R, Farokhzad OC. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc Natl Acad Sci U S A. 2011 Nov 29; 108(48):19347-52. PMID: 22087004.
    Citations: 42     Fields:    Translation:Animals
  127. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012; 63:185-98. PMID: 21888516.
    Citations: 407     Fields:    Translation:Humans
  128. Gao W, Farokhzad OC. Self-propelled microrockets to capture and isolate circulating tumor cells. Angew Chem Int Ed Engl. 2011 Aug 01; 50(32):7220-1. PMID: 21728224.
    Citations: 1     Fields:    Translation:HumansCells
  129. Shi J, Xiao Z, Votruba AR, Vilos C, Farokhzad OC. Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. Angew Chem Int Ed Engl. 2011 Jul 25; 50(31):7027-31. PMID: 21698724.
    Citations: 40     Fields:    Translation:HumansAnimalsCells
  130. Shi J, Xiao Z, Kamaly N, Farokhzad OC. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res. 2011 Oct 18; 44(10):1123-34. PMID: 21692448.
    Citations: 117     Fields:    Translation:HumansAnimals
  131. Valencia PM, Hanewich-Hollatz MH, Gao W, Karim F, Langer R, Karnik R, Farokhzad OC. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles. Biomaterials. 2011 Sep; 32(26):6226-33. PMID: 21658757.
    Citations: 40     Fields:    Translation:HumansAnimalsCells
  132. Rhee M, Valencia PM, Rodriguez MI, Langer R, Farokhzad OC, Karnik R. Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels. Adv Mater. 2011 Mar 25; 23(12):H79-83. PMID: 21433105.
    Citations: 45     Fields:    
  133. Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci U S A. 2011 Feb 01; 108(5):1850-5. PMID: 21233423.
    Citations: 155     Fields:    Translation:HumansAnimals
  134. Burgess P, Hutt PB, Farokhzad OC, Langer R, Minick S, Zale S. On firm ground: IP protection of therapeutic nanoparticles. Nat Biotechnol. 2010 Dec; 28(12):1267-70. PMID: 21139609.
    Citations: 22     Fields:    
  135. Gao W, Chan JM, Farokhzad OC. pH-Responsive nanoparticles for drug delivery. Mol Pharm. 2010 Dec 06; 7(6):1913-20. PMID: 20836539.
    Citations: 127     Fields:    
  136. Kolishetti N, Dhar S, Valencia PM, Lin LQ, Karnik R, Lippard SJ, Langer R, Farokhzad OC. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A. 2010 Oct 19; 107(42):17939-44. PMID: 20921363.
    Citations: 133     Fields:    Translation:Humans
  137. Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 2010 Sep 08; 10(9):3223-30. PMID: 20726522.
    Citations: 260     Fields:    
  138. Gao W, Langer R, Farokhzad OC. Poly(ethylene glycol) with observable shedding. Angew Chem Int Ed Engl. 2010 Sep 03; 49(37):6567-71. PMID: 20677297.
    Citations: 13     Fields:    Translation:Cells
  139. Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications. Nano Letters. 2010; Epub ahead of print.
  140. Gao W, Langer R, Farokhzad OC. Poly(ethylene glycol) with Observable Shedding. Angew Chem Int Ed Engl. 2010; Epub ahead of print.
  141. Ludwig FN, Hossainy SF, Svensson B, Sharkawy A, Cima M, Farokhzad OC, Magana J, Von Oepen R, Chow M, Webler WE, Yribarren TR, Ehrenreich KJ. Magnetically sensitive drug carriers and delivery devices. 2010.
  142. Farokhzad OC, Levy-Nissenbaum E, Langer RS, Alexis F. Oligonucleotide systems for targeted intracellular delivery. 2010.
  143. Farokhzad OC, Jon SY, Langer RS. Controlled release nanoparticle having bound oligonucleotide for targeted delivery. 2010.
  144. Alexis F, Shi J, Iannacone M, Moseman A, Basto P, Langer R, Farokhzad OC, von Andrian U. Adjuvant incorporation in immunonanotherapeutics. 2010.
  145. Shi J, Alexis F, Iannacone M, Moseman A, Basto P, Langer R, Farokhzad OC, von Andrian U. Targeting of antigen presenting cells with immunonanotherapeutics. 2010.
  146. Lippard SJ, Dhar S, Farokhzad OC, Kolishetti N, Gu FX. Nanostructures for drug delivery. 2010.
  147. Alexis F, Iannacone M, Shi J, Basto P, Moseman A, von Andrian U, Langer R, Farokhzad OC, Tonti E. Adjuvant incorporation in immunonanotherapeutics. 2010.
  148. Iannacone M, Alexis F, Basto P, Moseman A, Shi J, Langer R, Farokhzad OC, von Andrian U, Tonti E. Immunonanotherapeutics that provide IgG humoral response without T-cell antigen. 2010.
  149. von Andrian U, Farokhzad OC, Alexis F, Iannacone M, Basto P, Shi J, Moseman A, Langer R. Nicotine immunonanotherapeutics. 2010.
  150. Shi J, Alexis F, Iannacone M, Moseman A, Basto P, Langer R, Farokhzad OC, von Andrian U, Tonti E. Targeting of antigen presenting cells with immunonanotherapeutics. 2010.
  151. Iannacone M, von Andrian U, Farokhzad OC, Alexis F, Basto P, Shi J, Moseman A, Langer R, Tonti E. Nicotine immunonanotherapeutics. 2010.
  152. Farokhzad OC, Salvador-Morales C, Gao W, Zhang L, Chen JM, Langer RS. Particles with multiple functionalized surface domains. 2010.
  153. Von Andrian UH, Farokhzad OC, Langer RS, Junt T, Moseman A, Zhang L, Basto P, Iannacone M, Alexis F. Vaccine nanotechnology. 2010.
  154. Wang AZ, Yuet K, Zhang L, Gu FX, Huynh-Le M, Radovic-Moreno AF, Kantoff PW, Bander NH, Langer R, Farokhzad OC. ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation. Nanomedicine (Lond). 2010 Apr; 5(3):361-8. PMID: 20394530.